Abstract

We previously described the biosynthesis, isolation, and immunosuppressive activity of the selenium-containing polysaccharide fraction isolated from the mycelial culture of Lentinula edodes. Structural studies have shown that the fraction was a protein-containing mixture of high molar mass polysaccharides α- and β-glucans. However, which of the components of the complex fraction is responsible for the immunosuppressive activity non-typical for polysaccharides of fungal origin has not been explained. In the current study, we defined four-polysaccharide components of the Se-containing polysaccharide fraction determined their primary structure and examined the effect on T- and B-cell proliferation. The isolated Se-polysaccharides, α-1,4-glucan (Mw 2.25 × 106 g/mol), unbranched β-1,6-d-glucan, unbranched β-1,3-d-glucan and β-1,3-branched β-1,6-d-glucan (Mw 1.10 × 105 g/mol), are not typical as components of the cell wall of L. edodes. All are biologically active, but the inhibitory effect of the isolated polysaccharides on lymphocyte proliferation was weaker, though more selective than that of the crude fraction.

Highlights

  • Mushroom-derived polysaccharides (MPSs), β-D-glucans, are of great interest as immune-modulating substances recognized by the human immune system [1,2,3]

  • Composition of the Se-Le-30 (Se-Containing Lentinan Analog Isolated from Se-Enriched L. edodes Mycelium by the Chihara Method) Polysaccharide Fraction 2.1.1

  • We examined the effects of the isolated Se-polysaccharideprotein fraction (Se-L) on the proliferation of human peripheral blood mononuclear cell (PBMC) [30]

Read more

Summary

Introduction

Mushroom-derived polysaccharides (MPSs), β-D-glucans, are of great interest as immune-modulating substances recognized by the human immune system [1,2,3]. The cell wall β-D-glucans are typically 1,3- and 1,6-linked chains with varying amounts of side chains in position O-6 or O-3 [6,7,8]. Such a structure is described for lentinan, a highly purified polysaccharide fraction extracted from Lentinula edodes (shiitake mushroom) fruiting bodies. This substance is a highly potent enhancer of the immune system [9,10] approved for use in cancer treatment as an adjunct to conventional therapy [11,12,13]. Strain variation, developmental stage, culture method and conditions, medium composition, extraction method, and even drying method may result in variability in the monosaccharide composition and combinations among polysaccharides [15,16,17,18,19]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.